Rubiato, Gyne Kurl .

HRN: 21-07-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
CEFUROXIME 1.5GM (VIAL)
04/18/2026
04/19/2026
IV
1.5 Grams
Q8 X 3 Doses
SP NSD W RMLE, RBOW
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: